This process filters the blood to remove excess potassium and other wastes
Stopping your GLP-1 just to enjoy vacation food isnt usually dangerous, but it can lead to stronger cravings, less control around eating, and side effects when you restart
The biotech firm Metsera, which is developing a once-monthly GLP-1 injection, became the object of a bidding war between Pfizer and Novo Nordisk, with Pfizer emerging as the winner
95%CI 1.22-20.5), PSC/AIH overlap syndrome (HR 6.4
For this reason, many buyers turn toward established metabolic research peptides that already have stronger documentation frameworks, recognized third-party testing, and clearer sourcing transparency